{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:34:10Z","timestamp":1792672450891,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.biologicals.2012.07.005","type":"journal-article","created":{"date-parts":[[2012,8,11]],"date-time":"2012-08-11T03:19:12Z","timestamp":1344655152000},"page":"369-381","source":"Crossref","is-referenced-by-count":49,"title":["Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: State of the science and planning the way forward"],"prefix":"10.1016","volume":"40","author":[{"given":"William","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"McFarland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Kulpa-Eddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Gatewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayle","family":"Pulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gaydamaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Chapsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Gairola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wunderli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"McElhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"De Mattia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Gamoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Doelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Rinckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2012.07.005_bib1","unstructured":"Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Authorization Act. 2000. Public Law 106\u2013545."},{"key":"10.1016\/j.biologicals.2012.07.005_bib2","author":"NICEATM-ICCVAM"},{"key":"10.1016\/j.biologicals.2012.07.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.provac.2011.10.001","article-title":"Introduction and summary of the international workshop on alternative methods to reduce, refine, and replace the use of animals in vaccine potency and safety testing: state of the science and future directions","volume":"5","author":"Stokes","year":"2011","journal-title":"Proc Vaccinol"},{"key":"10.1016\/j.biologicals.2012.07.005_bib4","series-title":"The NICEATM-ICCVAM five-year plan (2008\u20132012): a plan to advance alternative test methods of high scientific quality to protect and advance the health of people, animals, and the environment","author":"Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM)","year":"2008"},{"key":"10.1016\/j.biologicals.2012.07.005_bib5","first-page":"923149","article-title":"Renewed global partnerships and redesigned roadmaps for rabies prevention and control","author":"Lembo","year":"2011","journal-title":"Vet Med Int"},{"key":"10.1016\/j.biologicals.2012.07.005_bib6","series-title":"WHO expert consultation on rabies","author":"WHO","year":"2005"},{"key":"10.1016\/j.biologicals.2012.07.005_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.virusres.2010.01.018","article-title":"Shimoni bat virus, a new representative of the Lyssavirus genus","volume":"149","author":"Kuzmin","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.biologicals.2012.07.005_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2460\/javma.239.6.773","article-title":"Rabies surveillance in the United States during 2010","volume":"239","author":"Blanton","year":"2011","journal-title":"JAVMA"},{"issue":"11","key":"10.1016\/j.biologicals.2012.07.005_bib9","doi-asserted-by":"crossref","first-page":"e839","DOI":"10.1371\/journal.pntd.0000839","article-title":"Rabies, still neglected after 125 years of vaccination","volume":"4","author":"Bouhry","year":"2010","journal-title":"PLOS Neglect Trop D"},{"key":"10.1016\/j.biologicals.2012.07.005_bib10","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2012.07.005_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vetmic.2006.04.009","article-title":"Canine vaccination\u2014providing broader benefits for disease control","volume":"117","author":"Cleaveland","year":"2006","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.biologicals.2012.07.005_bib12","first-page":"95","article-title":"Can rabies be eradicated?","volume":"131","author":"Rupprecht","year":"2008"},{"key":"10.1016\/j.biologicals.2012.07.005_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/biol.1996.0012","article-title":"Use of ELISA for in\u00a0vitro potency test of rabies vaccines for animal use","volume":"24","author":"Gamoh","year":"1996","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2012.07.005_bib14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1292\/jvms.65.685","article-title":"Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan","volume":"65","author":"Gamoh","year":"2003","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.biologicals.2012.07.005_bib15","series-title":"Minimum requirements: rabies vaccine, 3rd rev","author":"United States National Institutes of Health","year":"1953"},{"key":"10.1016\/j.biologicals.2012.07.005_bib16","series-title":"Laboratory techniques in rabies","first-page":"279","article-title":"The NIH test for potency","author":"Seligmann","year":"1973"},{"key":"10.1016\/j.biologicals.2012.07.005_bib17","first-page":"429","article-title":"Three Rs approaches in the quality control of inactivated rabies vaccines. ECVAM workshop report 48","volume":"31","author":"Bruckner","year":"2003","journal-title":"ATLA"},{"key":"10.1016\/j.biologicals.2012.07.005_bib18","series-title":"Monograph 04\/2008:0216. Rabies vaccine for human use prepared in cell cultures","author":"European Pharmacopoeia","year":"2011"},{"key":"10.1016\/j.biologicals.2012.07.005_bib19","first-page":"83","article-title":"Annex 2: recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs","volume":"vol. 941","author":"WHO","year":"2007"},{"key":"10.1016\/j.biologicals.2012.07.005_bib20","series-title":"Expert committee on biological standardization. Report of the WHO collaborative study to calibrate a replacement for the fifth international standard for rabies vaccine","author":"WHO","year":"2008"},{"key":"10.1016\/j.biologicals.2012.07.005_bib21","unstructured":"U.S. Code of Federal Regulations, Title 9, Chapter I: Animal and plant health inspection service, Department of Agriculture, Subchapter E \u2013 viruses, serums, toxins, and analogous products; organisms and vectors, Part 113.209, rabies vaccine, killed virus. Washington D.C., USA: U.S. Government Printing Office [updated 2010]."},{"key":"10.1016\/j.biologicals.2012.07.005_bib22","author":"United States Department of Agriculture"},{"key":"10.1016\/j.biologicals.2012.07.005_bib23","first-page":"37","article-title":"Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use","volume":"2","author":"Kr\u00e4mer","year":"2010","journal-title":"Pharmeur Biol Scientific Notes"},{"key":"10.1016\/j.biologicals.2012.07.005_bib24","unstructured":"Pharmeuropa Monograph XXXX:0451 \u2013 Rabies vaccine (inactivated) for veterinary use. 2011;23.1:128\u201331."},{"key":"10.1016\/j.biologicals.2012.07.005_bib25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biologicals.2009.01.001","article-title":"The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines","volume":"37","author":"Kr\u00e4mer","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2012.07.005_bib26","first-page":"491","article-title":"Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice","volume":"64","author":"Wunderli","year":"2003","journal-title":"Am J Vet Med"},{"key":"10.1016\/j.biologicals.2012.07.005_bib27","series-title":"Laboratory techniques in rabies","first-page":"360","article-title":"The NIH test for potency","author":"Wilbur","year":"1996"},{"issue":"2","key":"10.1016\/j.biologicals.2012.07.005_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ilar.41.2.59","article-title":"Reducing unrelieved pain and distress in laboratory animals using humane endpoints","volume":"41","author":"Stokes","year":"2000","journal-title":"ILAR J"},{"key":"10.1016\/j.biologicals.2012.07.005_bib29","series-title":"Monograph 07\/2010:0451. Rabies vaccine (inactivated) for veterinary use, Ph. Eur","author":"European Pharmacopoeia","year":"2011"},{"key":"10.1016\/j.biologicals.2012.07.005_bib30","unstructured":"Center for Veterinary Biologics Notice No. 04-09: Use of humane endpoints in animal testing of biological products. Title 9 Code of Federal Regulations (9CFR) Part 117.4(e); 2004."},{"key":"10.1016\/j.biologicals.2012.07.005_bib31","first-page":"40","article-title":"Humane endpoints for the estimation of lethality rates in the potency testing of rabies vaccines","volume":"15","author":"Cussler","year":"1998","journal-title":"Alternativen zu Tierexperimenten"},{"key":"10.1016\/j.biologicals.2012.07.005_bib32","author":"Humane endpoints in laboratory animal experimentation (HELP)"},{"key":"10.1016\/j.biologicals.2012.07.005_bib33","series-title":"Institutional animal care and use committee guidebook","author":"OLAW\/ARENA (Office of Laboratory Animal Welfare\/Applied Research Ethics National Association)","year":"2002"},{"key":"10.1016\/j.biologicals.2012.07.005_bib34","unstructured":"United States Animal Welfare Act. Transportation, sale, and handling of certain animals. Title 7. U.S. Code, Chapter 54 \u00a7 2131\u201359."},{"key":"10.1016\/j.biologicals.2012.07.005_bib35","first-page":"33","article-title":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes","volume":"276","author":"European Commission","year":"2010","journal-title":"Off J Eur Union L"},{"key":"10.1016\/j.biologicals.2012.07.005_bib36","unstructured":"Takayama-Ito M, Lim C, Saijo M. Humane endpoints in potency testing of rabies vaccine for human use in Japan. Poster presentation. International workshop on alternative methods for rabies vaccine testing: state of the science and planning the way forward, Ames, IA, USA, October, 2011."},{"key":"10.1016\/j.biologicals.2012.07.005_bib37","first-page":"1","article-title":"Directive 86\/609\/EEC of 24 November 1986 on the approximation of laws, regulations, and administrative provisions oc the member states regarding the protection of animals used for experimental and other scientific purposes","volume":"358","author":"European Commission","year":"1986","journal-title":"Off J Eur Union L"},{"key":"10.1016\/j.biologicals.2012.07.005_bib38","first-page":"198","article-title":"Evaluation of a sustained-release formulation of buprenorphine for analgesia in rats","volume":"50","author":"Foley","year":"2011","journal-title":"AALAS"},{"key":"10.1016\/j.biologicals.2012.07.005_bib39","author":"Center for Veterinary Biologics Notice No. 12-12"},{"key":"10.1016\/j.biologicals.2012.07.005_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2011.01.019","article-title":"A\u00a0non-invasive intranasal inoculation technique using isoflurane anesthesia to infect the brain of mice with rabies virus","volume":"173","author":"Rosseels","year":"2011","journal-title":"J\u00a0Virol Met"},{"issue":"49\u201350","key":"10.1016\/j.biologicals.2012.07.005_bib41","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1016\/j.vaccine.2006.06.078","article-title":"The rabies peripheral challenge test: more accurate determination of vaccine potency","volume":"24","author":"Wunderli","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2012.07.005_bib42","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals","article-title":"Rabies","author":"OIE","year":"2011"},{"key":"10.1016\/j.biologicals.2012.07.005_bib43","doi-asserted-by":"crossref","first-page":"811","DOI":"10.20506\/rst.1.3.82","article-title":"Test simplifi\u00e9 de contr\u00f4le d\u2019activit\u00e9 des vaccines antirabiques \u00e0 virus inactiv\u00e9s","volume":"1","author":"Aubert","year":"1982","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"10.1016\/j.biologicals.2012.07.005_bib44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF01941183","article-title":"Reduction in the number of mice used for potency testing of human and animal rabies vaccines","volume":"44","author":"Bruckner","year":"1988","journal-title":"Experientia"},{"key":"10.1016\/j.biologicals.2012.07.005_bib45","unstructured":"Bernard M, Wasniewski M, Gautheron S, Commandeur S, Otmani N, Caillet C, et\u00a0al. Towards the replacement of the NIH potency test: designing an immunogenicity study for human rabies vaccines in OF1 mice. Poster presentation. International workshop on alternative methods for rabies vaccine testing: state of the science and planning the way forward, Ames, IA, USA, October, 2011."},{"key":"10.1016\/j.biologicals.2012.07.005_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2012.07.005_bib47","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/BF01314961","article-title":"The glycoprotein G of rabdoviruses","volume":"140","author":"Coll","year":"1995","journal-title":"Arch Virol"},{"key":"10.1016\/j.biologicals.2012.07.005_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-1157(85)80042-1","article-title":"Use of monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay","volume":"13","author":"Lafon","year":"1985","journal-title":"J\u00a0Biol Stand"},{"key":"10.1016\/j.biologicals.2012.07.005_bib49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1045-1056(90)90037-Z","article-title":"In\u00a0vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody","volume":"18","author":"Perrin","year":"1990","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2012.07.005_bib50","series-title":"Laboratory techniques in rabies","first-page":"383","article-title":"Enzyme-linked immunosorbent assay (ELISA) for the determination of the glycoprotein content of rabies vaccines","author":"Perrin","year":"1996"},{"key":"10.1016\/j.biologicals.2012.07.005_bib51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1128\/JVI.73.1.225-233.1999","article-title":"Chimeric lyssavirus glycoproteins with increased immunological potential","volume":"73","author":"Jallet","year":"1999","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2012.07.005_bib52","first-page":"73","article-title":"Use of the single radial immunodiffusion test as a replacement fro the NIH mouse potency test for rabies vaccine","volume":"64","author":"Fitzgerald","year":"1986","journal-title":"Develop Biol Standard"},{"key":"10.1016\/j.biologicals.2012.07.005_bib53","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1045-1056(05)80051-X","article-title":"Rabies vaccine standardization: international collaborative study for the characterization of the fifth international standard for rabies vaccine","volume":"20","author":"Lyng","year":"1992","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2012.07.005_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1348-0421.1998.tb02270.x","article-title":"Antigenic and functional analyses of glycoprotein of rabies virus using monoclonal antibodies","volume":"42","author":"Luo","year":"1998","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.biologicals.2012.07.005_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","article-title":"A\u00a0simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture","volume":"34","author":"Nagarajan","year":"2006","journal-title":"Biologicals"},{"issue":"11","key":"10.1016\/j.biologicals.2012.07.005_bib56","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"M\u00fcller","year":"2009","journal-title":"PLOS Neglect Trop D"},{"key":"10.1016\/j.biologicals.2012.07.005_bib57","first-page":"541","article-title":"Common and different antigenic properties of the rabies virus glycoprotein of strains SAD-Vnukovo and Pitman-Moore","volume":"36","author":"M\u00e1\u010dikov\u00e1","year":"1992","journal-title":"Acta Virol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105612001066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105612001066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T08:15:22Z","timestamp":1687680922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105612001066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1045105612001066"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2012.07.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}